Showing promise in the field of obesity management, retatrutide is a distinct strategy. Unlike many existing medications, retatrutide functions as a dual agonist, at once engaging both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic polypeptide (GIP) sensors. This dual engagement encourages various helpful effects, like improved glucose… Read More